Axsome Therapeutics Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (28)

Latest Posts

About This Stock More About This Stock
These Were The Five Best And Worst Performing Mid-Cap Stocks In August 2022
Article By: ValueWalk
Tuesday, September 20, 2022 4:57 AM EST
We have used the August return data from finviz.com to come up with the five best and worst performing mid-cap stocks in August 2022.
In this article: GET, SITM, NVAX, TNDM, CCXI, GBT, AXSM, KRTX, ASTS
Read
Stocks That Made New Highs On Friday, Aug. 19
Article By: Fred Fuld
Sunday, August 21, 2022 5:46 AM EST
On Friday, in spite of the stock market being down, there were several stocks that actually made new highs.
In this article: NL, ARTNA, ICPT, SUPN, ADMA, AXSM
Read
Best Biotech Stocks To Buy In 2022
Article By: Elliottwave Forecast
Tuesday, March 15, 2022 6:42 AM EST
Biotechnology is the study of living creatures, biological systems, or derivatives to develop or improve healthcare products and therapies. This technology is connected with medical and pharmaceuticals, genomics, and food and chemical manufacturing.
In this article: BMY, JNJ, PFE, NVAX, REGN, AMGN, VRTX, AXSM, GMAB, RLAY
Read
Alzheimer's Disease: 5 Stocks On Biotech Radars
Video By: Kevin Cook
Thursday, April 22, 2021 7:53 PM EST
What's been interesting for the past couple of years, and especially the last few months, is to watch the rise of emerging, small-cap Biotech companies trying to take on the big AD and other neurological and CNS diseases.
In this video: AVXL, JAZZ, BIIB, AXSM, SAVA
Watch
VistaGen Is Prepared For 2021 Fueled By Recent Analyst Upgrades And Large Institutional Buyers
Article By: Moon Kil Woong
Friday, January 8, 2021 11:59 AM EST
VistaGen’s deal with Pherin Pharmaceuticals to develop PH-94B has positioned the Company to grab a healthy share of, social anxiety, and major depression markets.
In this article: JNJ, SAGE, CNSP, AXSM, RLMD, VTGN
Read

Latest Tweets for $AXSM

No tweets yet!

PARTNER HEADLINES